Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
5369 | 1565 | 47.2 | 94% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | PDK1 | Author keyword | 33 | 44% | 4% | 56 |
2 | AKT ISOFORMS | Author keyword | 21 | 75% | 1% | 15 |
3 | AKT2 | Author keyword | 14 | 34% | 2% | 35 |
4 | AKT1 | Author keyword | 12 | 22% | 3% | 50 |
5 | AGC KINASE | Author keyword | 11 | 52% | 1% | 15 |
6 | PKB | Author keyword | 9 | 18% | 3% | 47 |
7 | MK 2206 | Author keyword | 9 | 52% | 1% | 12 |
8 | PROTEIN KINASE B | Author keyword | 8 | 12% | 4% | 64 |
9 | AKT INHIBITORS | Author keyword | 8 | 56% | 1% | 10 |
10 | AKT KINASE INHIBITORS | Author keyword | 8 | 100% | 0% | 5 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PDK1 | 33 | 44% | 4% | 56 | Search PDK1 | Search PDK1 |
2 | AKT ISOFORMS | 21 | 75% | 1% | 15 | Search AKT+ISOFORMS | Search AKT+ISOFORMS |
3 | AKT2 | 14 | 34% | 2% | 35 | Search AKT2 | Search AKT2 |
4 | AKT1 | 12 | 22% | 3% | 50 | Search AKT1 | Search AKT1 |
5 | AGC KINASE | 11 | 52% | 1% | 15 | Search AGC+KINASE | Search AGC+KINASE |
6 | PKB | 9 | 18% | 3% | 47 | Search PKB | Search PKB |
7 | MK 2206 | 9 | 52% | 1% | 12 | Search MK+2206 | Search MK+2206 |
8 | PROTEIN KINASE B | 8 | 12% | 4% | 64 | Search PROTEIN+KINASE+B | Search PROTEIN+KINASE+B |
9 | AKT INHIBITORS | 8 | 56% | 1% | 10 | Search AKT+INHIBITORS | Search AKT+INHIBITORS |
10 | AKT KINASE INHIBITORS | 8 | 100% | 0% | 5 | Search AKT+KINASE+INHIBITORS | Search AKT+KINASE+INHIBITORS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PROTEIN KINASE B | 46 | 13% | 21% | 334 |
2 | PKB INHIBITORS | 45 | 94% | 1% | 16 |
3 | C AKT | 31 | 46% | 3% | 50 |
4 | PDK1 | 24 | 33% | 4% | 58 |
5 | 3 PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1 | 22 | 40% | 3% | 44 |
6 | PLECKSTRIN HOMOLOGY DOMAIN | 20 | 11% | 11% | 178 |
7 | AKT PKB | 18 | 24% | 4% | 66 |
8 | PKB AKT | 13 | 40% | 2% | 25 |
9 | IN VIVO ROLE | 13 | 47% | 1% | 20 |
10 | PHOSPHOINOSITIDE DEPENDENT KINASE 1 | 12 | 75% | 1% | 9 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
AKT/PKB signaling: Navigating downstream | 2007 | 2173 | 109 | 25% |
Akt signalling in health and disease | 2011 | 232 | 225 | 34% |
The nuts and bolts of AGC protein kinases | 2010 | 381 | 150 | 22% |
PI3K/Akt: getting it right matters | 2008 | 263 | 222 | 34% |
The activation of Akt/PKB signaling pathway and cell survival | 2005 | 729 | 96 | 42% |
Distinct Biological Roles for the Akt Family in Mammary Tumor Progression | 2010 | 75 | 21 | 62% |
Advances in protein kinase B signalling: AKTion on multiple fronts | 2004 | 518 | 74 | 49% |
Advances of AKT pathway in human oncogenesis and as a target for anti-cancer drug discovery | 2008 | 84 | 40 | 73% |
PDK1, the master regulator of AGC kinase signal transduction | 2004 | 386 | 69 | 57% |
Ten years of protein kinase B signalling: a hard Akt to follow | 2001 | 764 | 62 | 55% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GRP PHOSPHOSITES | 5 | 44% | 0.5% | 8 |
2 | ONCOL DRUG METAB PHARMACOKINET | 3 | 100% | 0.2% | 3 |
3 | STRUCT BIOCHEM UNIT | 3 | 50% | 0.3% | 4 |
4 | PATHOL INTERDISCIPLINARY ONCOL | 2 | 67% | 0.1% | 2 |
5 | ONCOL BIOL | 2 | 18% | 0.6% | 9 |
6 | R47S | 1 | 31% | 0.3% | 4 |
7 | DIPARTIMENTO SCI ANAT UMANE FISIOPATOL PARATO | 1 | 13% | 0.6% | 10 |
8 | MOL CELLULAR BIOL NUTR SCI | 1 | 100% | 0.1% | 2 |
9 | PHARMACOLMETAB DIS CELL SIGNALING | 1 | 100% | 0.1% | 2 |
10 | SELECTSCREEN SERV | 1 | 100% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000164790 | P110 ALPHA//PIK3CA//PI3K ALPHA |
2 | 0.0000111305 | MTOR//RAPAMYCIN//CCI 779 |
3 | 0.0000102532 | PTEN//LHERMITTE DUCLOS DISEASE//COWDEN SYNDROME |
4 | 0.0000096670 | SGK1//SERUM AND GLUCOCORTICOID INDUCIBLE KINASE//SERUM AND GLUCOCORTICOID INDUCIBLE KINASE |
5 | 0.0000092774 | PKN//PROTEIN KINASE C RELATED KINASE//PRK1 |
6 | 0.0000089557 | FOXO//FOXO3A//FOXO1 |
7 | 0.0000078331 | S6K2//S6 KINASE//RIBOSOMAL S6 KINASE 2 S6K2 |
8 | 0.0000072524 | INSULIN RECEPTOR SUBSTRATE//INSULIN RECEPTOR SUBSTRATE 1//IRS 1 |
9 | 0.0000071024 | BIOL CHEMBUNKYO KU//DEMETHOXYVIRIDIN//2 4 MORPHOLINYL 8 PHENYLCHROMONE |
10 | 0.0000064972 | SHIP2//INOSITOL 5 PHOSPHATASE//SHIP1 |